美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CAR-T

1,345.76

+24.191.83%

漲家數：2

跌家數：1

平家數：- -

市盈率：- -

高：1,357.18

開：1,347.70

低：1,336.48

收：1,321.57

資料載入中...

諾華製藥盤中異動早盤急速拉昇3.15%

吉利德科學5月1日成交額為7.55億美元

吉利德科學盤中異動早盤股價大跌3.03%報103.31美元

吉利德科學4月30日成交額為10.17億美元

藍鳥生物盤中異動早盤急速跳水5.10%報3.91美元

諾華將斥資至多17億美元收購生物技術公司Regulus Therapeutics

諾華(NVS.US)擬以至多17億美元收購Regulus Therapeutics(RGLS.US)

【吉利德科學與美國政府達成2億美元和解協議】吉利德科學與美國政府達成2.02億美元的和解協議，以解決其向醫生支付費用併為他們提供活動餐費和差旅費以讓其開出其藥物的指控。曼哈頓聯邦檢察官指控，吉利德從2011年1月至2017年11月實施部分計劃，以推廣和增加其治療艾滋病毒的藥物的銷售量。該等活動原本純粹是為了教育目的，並提供簡單的餐點，但該公司在高檔餐廳舉辦活動。檢察官稱，許多醫生隨後開出該公司的藥物，迫使聯邦醫療保健計劃為該等處方支付數百萬美元的報銷費用。

吉利德科學公司在美國就艾滋病藥物回扣問題達成和解，將支付 2.02 億美元

吉利德科學公司就醫生回扣問題與美國達成 2.02 億美元和解協議

諾華製藥漲1.35% 一季度業績超預期上調全年淨銷售額增長指引

瑞士製藥巨頭諾華上調2025年預期受第一季度強勁增長推動

环球市场播报

諾華製藥(NVS.US)Q1業績超預期上調全年增長目標

諾華製藥Q1業績超預期上調全年增長目標

諾華上調今年營業利潤增長預期

环球市场播报

諾華第一季度核心每股收益2.28美元，預估2.11美元。

Sui生態部分代幣漲勢延續，DEEP 24小時漲超12.99%

吉利德科學4月28日成交額為9.98億美元

【現貨黃金漲0.8%，金銀礦業股普遍收漲】週一紐約尾盤，現貨黃金漲0.81%，報3346.65美元/盎司，日內大部分時間交投於3300美元下方，北京時間20:00開啓一波“相對顯著”的上漲行情。COMEX黃金期貨漲1.83%，報3358.90美元/盎司，日內大部分時間交投於3300美元附近，整體呈現出U形走勢。費城金銀指數收漲0.95%，報187.78點。成分股安格魯阿山帝黃金公司漲4.14%，SSR礦業漲3.71%，金田漲2.48%表現第三，在收跌的四隻成分股中，自由港跌0.29%，New Gold跌0.59%，布埃納文圖拉礦業跌1.3%，諾華黃金跌2.03%。

吉利德科學盤中異動股價大漲3.00%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4578/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1345.7642,"timestamp":1746215999999,"preClose":1321.5748,"halted":0,"volume":9241330,"delay":0,"changeRate":0.018303,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":24.189331,"latestTime":"05-02 16:00:00 EDT","open":1347.704,"high":1357.1796,"low":1336.4781,"amount":968699197.233112,"amplitude":0.015664,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.104359,"peRate":18.860207,"turnoverRate":0.003021,"increases":2,"decrements":1,"flats":0,"marketCap":355022688696,"floatMarketCap":335368900736},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1357.1796,"amplitude":0.015664,"preClose":1321.5748,"low":1336.4781,"pbRate":"6.104359","latestPrice":1345.7642,"volume":9241330,"delay":0,"open":1347.704,"prevYearClose":1164.883,"prevWeekClose":1327.2651,"prevMonthClose":1353.2946,"prevQuarterClose":1364.0579,"fiveDayClose":1327.2651,"twentyDayClose":1371.8842,"sixtyDayClose":1292.9265,"secType":"PLATE","market":"US","turnoverRate":0.003021,"peRate":18.860207,"marketCap":355022688696,"floatMarketCap":335368900736,"timestamp":1746215999999,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":2,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532415028","title":"諾華製藥盤中異動 早盤急速拉昇3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532415028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532415028?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 21:31","pubTimestamp":1746192700,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时31分，诺华制药股票出现异动，股价大幅拉升3.15%。截至发稿，该股报114.84美元/股，成交量49.354万股，换手率0.02%，振幅0.15%。机构评级方面，在所有26家参与评级的机构中，15%的券商给予买入建议，69%的券商给予持有建议，16%的券商给予卖出建议。诺华制药股票所在的制药行业中，整体涨幅为2.55%。诺华制药公司简介：诺华开发和生产创新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213140a4700397&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213140a4700397&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009355771.USD","BK4007","NVS","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0211331839.USD","IE00B2B36J28.USD","LU0070302665.USD","BK4585","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0320765489.SGD","BK4588","BK4578","BK4532"],"gpt_icon":0},{"id":"2532851905","title":"吉利德科學5月1日成交額為7.55億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532851905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532851905?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 09:36","pubTimestamp":1746149798,"startTime":"0","endTime":"0","summary":"美东时间2025年5月1日，吉利德科学成交额为7.55亿美元，成交额较昨日减少25.78%，当日成交量为727.09万股。吉利德科学于2025年5月1日跌3.09%，报103.25美元，该股过去5个交易日跌2.73%，年初至今涨12.57%，过去60日涨6.11%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502093645a46f7d25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502093645a46f7d25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4585","LU1585245621.USD","LU1571399168.USD","IE00B19Z3B42.SGD","BK4566","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4588","BK4532","LU2468319806.SGD","LU1430594728.SGD","LU2089984988.USD","LU1839511570.USD","LU0109394709.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4568","IE0002270589.USD","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4583","LU1066053197.SGD","LU0289739699.SGD","GILD","BK4139","BK4578","LU0320765992.SGD","LU1066051498.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2532008426","title":"吉利德科學盤中異動 早盤股價大跌3.03%報103.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532008426?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 21:47","pubTimestamp":1746107241,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时47分，吉利德科学股票出现波动，股价快速下跌3.03%。截至发稿，该股报103.31美元/股，成交量56.4398万股，换手率0.05%，振幅2.34%。吉利德科学股票所在的制药行业中，整体跌幅为4.03%。消息层面，截至21时47分，《吉利德科学与美国政府达成2亿美元和解协议》资讯为影响吉利德科学的重要信息。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501214721974c9934&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501214721974c9934&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1066053197.SGD","LU1066051498.USD","BK4568","BK4532","LU2087621335.USD","BK4566","LU1430594728.SGD","IE0002270589.USD","LU2468319806.SGD","LU1585245621.USD","GILD","IE00BZ1G4Q59.USD","BK4578","LU0320765992.SGD","IE00B3T34201.USD","BK4139","BK4585","BK4583","BK4550","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0058720904.USD","LU2089984988.USD","LU0889565916.HKD","IE00BSNM7G36.USD","LU1839511570.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","LU0234570918.USD","LU0109394709.USD","LU1571399168.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2532179910","title":"吉利德科學4月30日成交額為10.17億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532179910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532179910?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 09:36","pubTimestamp":1746063390,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，吉利德科学成交额为10.17亿美元，成交额较昨日增加26.46%，当日成交量为962.85万股。吉利德科学于2025年4月30日涨2.24%，报106.54美元，该股过去5个交易日涨0.15%，年初至今涨16.15%，过去60日涨9.06%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501093634a46e6670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501093634a46e6670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1839511570.USD","IE00B3T34201.USD","BK4585","IE00B7SZLL34.SGD","BK4139","BK4578","LU0058720904.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1571399168.USD","LU0109394709.USD","BK4568","LU1066051498.USD","LU2468319806.SGD","IE00BKVL7J92.USD","LU1430594728.SGD","LU0889565916.HKD","BK4550","BK4583","BK4532","LU2089984988.USD","BK4566","LU2087621335.USD","LU0289739699.SGD","LU0320765992.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","IE0002270589.USD","LU0234570918.USD","GILD","IE00B19Z3581.USD","BK4588"],"gpt_icon":0},{"id":"2531529240","title":"藍鳥生物盤中異動 早盤急速跳水5.10%報3.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531529240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531529240?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 22:52","pubTimestamp":1746024723,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日22时52分，蓝鸟生物股票出现异动，股价快速下跌5.10%。截至发稿，该股报3.91美元/股，成交量2.9281万股，换手率0.30%，振幅2.91%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nutriband Inc C/Wts 涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Onconetix, Inc.较为活跃，换手率分别为145.82%、30.27%、19.42%，振幅较大的相关个股有Nutriband Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为29.23%、28.00%、25.11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430225203a46dd76c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430225203a46dd76c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BK4556","BLUE","BK4139"],"gpt_icon":0},{"id":"2531053008","title":"諾華將斥資至多17億美元收購生物技術公司Regulus Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2531053008","media":"格隆汇","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531053008?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 21:26","pubTimestamp":1746019596,"startTime":"0","endTime":"0","summary":"诺华制药宣布，达成收购美国生物技术公司Regulus Therapeutics的协议，交易包括8亿美元预付款，达到未来监管里程碑后可能额外支付至多9亿美元。该交易预计将于今年下半年完成。Regulus致力于开发microRNA疗法，专注于治疗常染色体显性多囊肾病(ADPKD)。\n\n\r\n            责任编辑：山上","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/04/30212650061134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4139","LU0070302665.USD","LENZ","LU0320765489.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4585","LU0208291251.USD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00B2B36J28.USD","BK4578","BK4007","LU0211331839.USD","BK4588","BK4532","NVS"],"gpt_icon":0},{"id":"2531037523","title":"諾華(NVS.US)擬以至多17億美元收購Regulus Therapeutics(RGLS.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2531037523","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531037523?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 20:59","pubTimestamp":1746017941,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药周三发布声明称，已达成协议将收购美国生物技术公司Regulus Therapeutics Inc.，这笔交易最高价值可达17亿美元。Regulus Therapeutics专注于研发靶向微小核糖核酸的疗法，这种分子能够调控细胞功能。Regulus Therapeutics首席执行官杰伊·哈根表示，诺华强大的全球研发和商业化能力，将助力公司核心产品farabursen成功推向市场。受此消息影响，Regulus Therapeutics股价在周三美股盘前飙升，截至发稿，上涨134%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211331839.USD","LU0208291251.USD","LU0070302665.USD","BK4585","BK4578","IE00BFTCPJ56.SGD","LU0320765489.SGD","LENZ","NVS","BK4532","IE00B2B36J28.USD","BK4139","IE0009355771.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4007","IE0002141913.USD","BK4588","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2531749214","title":"【吉利德科學與美國政府達成2億美元和解協議】吉利德科學與美國政府達成2.02億美元的和解協議，以解決其向醫生支付費用併為他們提供活動餐費和差旅費以讓其開出其藥物的指控。曼哈頓聯邦檢察官指控，吉利德從2011年1月至2017年11月實施部分計劃，以推廣和增加其治療艾滋病毒的藥物的銷售量。該等活動原本純粹是為了教育目的，並提供簡單的餐點，但該公司在高檔餐廳舉辦活動。檢察官稱，許多醫生隨後開出該公司的藥物，迫使聯邦醫療保健計劃為該等處方支付數百萬美元的報銷費用。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531749214","media":"金融界","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531749214?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 09:07","pubTimestamp":1745975247,"startTime":"0","endTime":"0","summary":"吉利德科学与美国政府达成2.02亿美元的和解协议，以解决其向医生支付费用并为他们提供活动餐费和差旅费以让其开出其药物的指控。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。该等活动原本纯粹是为了教育目的，并提供简单的餐点，但该公司在高档餐厅举办活动。检察官称，许多医生随后开出该公司的药物，迫使联邦医疗保健计划为该等处方支付数百万美元的报销费用。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30090750029382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4566","BK4583","BK4532","LU2089984988.USD","IE00BKVL7J92.USD","LU1430594728.SGD","BK4585","LU1839511570.USD","LU2468319806.SGD","BK4139","LU1066051498.USD","IE00B19Z3B42.SGD","LU0058720904.USD","IE0002270589.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","BK4568","LU0320765992.SGD","IE00B19Z3581.USD","BK4578","LU1066053197.SGD","LU0889565916.HKD","LU1571399168.USD","LU0234570918.USD","LU0289739699.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","GILD","IE00B3T34201.USD","LU0109394709.USD","LU2087621335.USD","BK4588","BK4550"],"gpt_icon":0},{"id":"2531760523","title":"吉利德科學公司在美國就艾滋病藥物回扣問題達成和解，將支付 2.02 億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531760523","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531760523?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 02:31","pubTimestamp":1745951487,"startTime":"0","endTime":"0","summary":"更新版 1-吉利德科学公司在美国就艾滋病药物回扣问题达成和解，将支付 2.02 亿美元改写第一段；添加吉利德公司和美国律师的评论、指控、举报人详情、财务影响、署名Jonathan Stempel. 路透纽约4月29日 - 吉利德科学公司同意支付2.02亿美元，以了结一起举报人诉讼，该诉讼指控吉利德向同意开具其艾滋病药物处方的医生支付回扣，涉嫌民事欺诈。2024 年，吉利德的艾滋病药物销售总额达 196.1 亿美元，同比增长 8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R728V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","IE00B3T34201.USD","BK4139","GILD","LU1585245621.USD","IE00B7SZLL34.SGD","LU2089984988.USD","LU2087621335.USD","IE00BSNM7G36.USD","BK4578","LU1066051498.USD","BK4566","BK4568","LU1066053197.SGD","BK4583","LU0889565916.HKD","BK4550","LU0234570918.USD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","BK4585","LU1430594728.SGD","BK4532","LU2468319806.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU0109394709.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2531764411","title":"吉利德科學公司就醫生回扣問題與美國達成 2.02 億美元和解協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2531764411","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531764411?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 01:39","pubTimestamp":1745948380,"startTime":"0","endTime":"0","summary":"吉利德科学公司就医生回扣问题与美国达成 2.02 亿美元和解协议路透纽约4月29日 - 美国曼哈顿检察官办公室周二表示，吉利德科学公司GILD.O已达成一项2.02亿美元的和解协议，以解决一起指控该公司向同意处方其艾滋病药物的医生支付回扣的民事欺诈诉讼。该和解协议解决了吉利德公司向参加吉利德公司演讲活动的医生支付酬金、餐费和差旅费，以诱使他们开具几种艾滋病药物处方的指控。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R7264:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU1430594728.SGD","BK4578","BK4588","LU0234570918.USD","IE00BKVL7J92.USD","LU1066051498.USD","LU1066053197.SGD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0320765992.SGD","LU2089984988.USD","LU0889565916.HKD","IE0002270589.USD","LU1571399168.USD","IE00B19Z3B42.SGD","BK4139","LU1585245621.USD","LU2468319806.SGD","IE00BSNM7G36.USD","LU0058720904.USD","LU1839511570.USD","BK4532","LU2087621335.USD","BK4550","LU0289739699.SGD","BK4566","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","LU0109394709.USD","BK4585","GILD","BK4583"],"gpt_icon":0},{"id":"2531775784","title":"諾華製藥漲1.35% 一季度業績超預期 上調全年淨銷售額增長指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2531775784","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531775784?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 23:25","pubTimestamp":1745940320,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺华制药(NVS)股价走高，截止发稿，涨1.35%，报114.15美元。消息面上，公司一季度业绩显示，经调整后核心营业利润达55.8亿美元，同比增长27%，高于市场预期的50.7亿美元；核心每股收益增长31%至2.28美元。期内，营收132亿美元，高于分析师普遍预期的131.2亿美元。公司CEO表示，公司重点品牌包括Kisqali、Kesimpta和Leqvio继续展现强劲势头，预计这将推动公司在2030年及以后的增长。展望未来，公司将2025年全年净销售额增长指引从中高个位数上调至高个位数，核心营业利润增长指引从高个位数至低双位数调整为低双位数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429232640974a5c17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429232640974a5c17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD","IE0009355771.USD","BK4532","BK4585","IE0002141913.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0070302665.USD","BK4578","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4007","LU0208291251.USD","NVS","BK4588"],"gpt_icon":0},{"id":"2531385227","title":"瑞士製藥巨頭諾華上調2025年預期 受第一季度強勁增長推動","url":"https://stock-news.laohu8.com/highlight/detail?id=2531385227","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531385227?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 15:20","pubTimestamp":1745911200,"startTime":"0","endTime":"0","summary":"瑞士制药企业诺华集团NOVN.S周二公布了更为乐观的全年盈利预期，得益于第一季度Leqvio、Kisqali和Kesimpta等药物的强劲表现。　　该公司在声明中表示，剔除非经常性项目后，预计2025年营业利润将实现“低双位数”增长。此前该公司对今年的增长预期为“高单位数至低双位数”，而2024年该指标实际增幅达22%。其乳腺癌药物Kisqali季度营收飙升52%至9.56亿美元，降胆固醇药物Leqvio销售额增长70%至2.57亿美元，在初期推广缓慢后实现加速放量，两者均超出市场预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-04-29/doc-ineuvhrz5191711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4532","NVS","BK1574","IE0002141913.USD","IE00B4R5TH58.HKD","LU0070302665.USD","BK4588","BK4578","LU0320765489.SGD","LU0211331839.USD","BK1191","IE0009355771.USD","IE00BJT1NW94.SGD","LU0208291251.USD","IE00BFTCPJ56.SGD","BK4585","BK4007","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","01477"],"gpt_icon":0},{"id":"2531221283","title":"諾華製藥(NVS.US)Q1業績超預期 上調全年增長目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2531221283","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531221283?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 14:55","pubTimestamp":1745909708,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药商诺华制药周二公布了好于预期的第一季度销售额，并上调了全年业绩指引。此次业绩增长主要得益于心衰治疗药物Entresto和关节炎药物Cosentyx这两款畅销药的持续发力。此次财报发布之际，全球制药行业正密切关注美国可能加征的关税措施。继诺华制药之后，瑞士制药企业罗氏上周也宣布将在美国投资500亿美元，并创造超过1.2万个就业岗位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4578","01477","LU0070302665.USD","IE00BJT1NW94.SGD","NVS","LU0208291251.USD","BK4532","IE00B2B36J28.USD","BK1574","BK4585","IE0002141913.USD","BK1191","LU0320765489.SGD","IE00BJJMRZ35.SGD","BK4007","BK4588","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0211331839.USD"],"gpt_icon":0},{"id":"2531241022","title":"諾華製藥Q1業績超預期上調全年增長目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2531241022","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531241022?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 14:55","pubTimestamp":1745909700,"startTime":"0","endTime":"0","summary":"诺华制药2023年第一季度业绩超出预期，净销售额同比增长15%至132亿美元，核心营业利润达55.8亿美元，同比增长27%。公司上调了全年净销售额和核心营业利润增长目标，主要得益于Entresto、Cosentyx等畅销药的强劲表现以及Kisqali、Kesimpta和Leqvio等新产品的市场需求增长。尽管面临仿制药竞争压力，诺华制药仍通过加速创新疗法布局和加大在美国的投资来应对挑战，并对未来增长充满信心。此外，公司还宣布未来五年将在美国投资230亿美元，新建和扩建生产基地以优化本土化生产布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042915061794e7188c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042915061794e7188c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","NVS","BK4007","BK4532","BK4578","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0070302665.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","LU0211331839.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2531240113","title":"諾華上調今年營業利潤增長預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2531240113","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531240113?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 13:24","pubTimestamp":1745904240,"startTime":"0","endTime":"0","summary":"诺华周二发布了更为乐观的全年盈利预期，称Kisqali、Kesimpta和Leqvio等药物的销售在第一季度实现强劲增长。\n　　这家瑞士制药商在一份声明中表示，预计2025年经特殊项目调整后的营业利润将以“低两位数”的百分比增长。\n　　该公司此前预测的增长率为“高个位数到低两位数”，而2024年的增长率为22%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：于健 SF069","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-04-29/doc-ineuvhru4266683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVS","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","BK4578","BK4585","IE00B2B36J28.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0070302665.USD","LU0211331839.USD","IE00BJT1NW94.SGD","BK4007","BK4532","LU0320765489.SGD","BK4588","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2531247244","title":"諾華第一季度核心每股收益2.28美元，預估2.11美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531247244","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531247244?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 13:09","pubTimestamp":1745903354,"startTime":"0","endTime":"0","summary":"诺华第一季度核心每股收益2.28美元，预估2.11美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/29130949988909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0208291251.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0070302665.USD","IE0002141913.USD","IE00B4R5TH58.HKD","BK4532","LU0211331839.USD","BK4578","BK4585","BK4007","LU0320765489.SGD","IE00BFTCPJ56.SGD","NVS","BK4588","IE00BJJMRZ35.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2531212546","title":"Sui生態部分代幣漲勢延續，DEEP 24小時漲超12.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531212546","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531212546?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 10:21","pubTimestamp":1745893260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/291635","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BK4139","BK4556","DEEP","BLUE","BK4578"],"gpt_icon":0},{"id":"2531151752","title":"吉利德科學4月28日成交額為9.98億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531151752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531151752?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:35","pubTimestamp":1745890518,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，吉利德科学成交额为9.98亿美元，成交额较昨日减少31.77%，当日成交量为945.89万股。吉利德科学于2025年4月28日涨3.07%，报106.34美元，该股过去5个交易日涨1.93%，年初至今涨15.94%，过去60日涨10.46%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429093523a6cc72cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429093523a6cc72cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU1571399168.USD","LU1839511570.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU2089984988.USD","LU2468319806.SGD","LU0058720904.USD","BK4583","IE00BSNM7G36.USD","LU0289739699.SGD","BK4550","BK4139","IE00B19Z3B42.SGD","BK4585","BK4566","LU1066051498.USD","BK4578","IE00BKVL7J92.USD","LU0234570918.USD","BK4532","LU2087621335.USD","LU0889565916.HKD","LU1430594728.SGD","LU0109394709.USD","LU1585245621.USD","LU1066053197.SGD","BK4568","IE00B19Z3581.USD","IE0002270589.USD","BK4588"],"gpt_icon":0},{"id":"2531126990","title":"【現貨黃金漲0.8%，金銀礦業股普遍收漲】週一紐約尾盤，現貨黃金漲0.81%，報3346.65美元/盎司，日內大部分時間交投於3300美元下方，北京時間20:00開啓一波“相對顯著”的上漲行情。COMEX黃金期貨漲1.83%，報3358.90美元/盎司，日內大部分時間交投於3300美元附近，整體呈現出U形走勢。費城金銀指數收漲0.95%，報187.78點。成分股安格魯阿山帝黃金公司漲4.14%，SSR礦業漲3.71%，金田漲2.48%表現第三，在收跌的四隻成分股中，自由港跌0.29%，New Gold跌0.59%，布埃納文圖拉礦業跌1.3%，諾華黃金跌2.03%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531126990","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531126990?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 04:55","pubTimestamp":1745873726,"startTime":"0","endTime":"0","summary":"周一纽约尾盘，现货黄金涨0.81%，报3346.65美元/盎司，日内大部分时间交投于3300美元下方，北京时间20:00开启一波“相对显著”的上涨行情。COMEX黄金期货涨1.83%，报3358.90美元/盎司，日内大部分时间交投于3300美元附近，整体呈现出U形走势。费城金银指数收涨0.95%，报187.78点。成分股安格鲁阿山帝黄金公司涨4.14%，SSR矿业涨3.71%，金田涨2.48%表现第三，在收跌的四只成分股中，自由港跌0.29%，New Gold跌0.59%，布埃纳文图拉矿业跌1.3%，诺华黄金跌2.03%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/29045549977048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0208291251.USD","LU0211331839.USD","IE0009355771.USD","BK4532","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4585","159831","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","NVS","LU0320765489.SGD","BK4588","LU1223082196.USD","GFI","IE00BFTCPJ56.SGD","LU1223083913.SGD","BK4578","BK4017","LU1223082519.USD","BK4007","LU0070302665.USD"],"gpt_icon":0},{"id":"2531646022","title":"吉利德科學盤中異動 股價大漲3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531646022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531646022?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 03:27","pubTimestamp":1745868465,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日03时27分，吉利德科学股票出现异动，股价快速拉升3.00%。吉利德科学股票所在的制药行业中，整体涨幅为0.24%。吉利德科学公司简介：吉利德科学开发和营销用于治疗威胁生命的传染病的疗法，其投资组合的核心集中在艾滋病毒，乙型和丙型肝炎。消息层面，截至03时27分，《大摩：维持Gilead Sciences评级，由增持调整至增持评级, 目标价由130.00美元调整至135.00美元。》资讯为影响吉利德科学的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042903274594e64b2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042903274594e64b2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00B19Z3B42.SGD","LU1839511570.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BK4585","LU0234570918.USD","GILD","LU0889565916.HKD","LU2089984988.USD","LU0289739699.SGD","BK4583","BK4550","IE00BZ1G4Q59.USD","LU1066053197.SGD","BK4139","IE00B19Z3581.USD","LU1066051498.USD","BK4532","LU0109394709.USD","LU1571399168.USD","LU2087621335.USD","BK4566","LU1585245621.USD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU1430594728.SGD","LU2468319806.SGD","BK4568","IE0002270589.USD","BK4578","LU0320765992.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}]}}